Table 4.
Study or reference | CL/F |
V/F |
AUCb |
t1/2 (h) |
||||
---|---|---|---|---|---|---|---|---|
Mean (liters/h) | Δ% | Mean (liters) | Δ% | Mean (μg-h/liter) | Δ% | Mean | Δ% | |
Present study | 461 (9.07c) | 589 (11.7d) | 173 | 1.22 | ||||
28 | 8.29c | +5 | 11.0d | +6 | NA | 1.01 | +21 | |
7 | 550 | −16 | 1,720 | −66 | 152 | +14 | 2.21 | −45 |
19 | 529 | −13 | NA | 156 | +12 | 2.2 | −45 | |
23 | 642 | −28 | NA | 141 | +23 | 2.30 | −47 | |
1 | 653 | −29 | 1,350 | −56 | 119 | +46 | 1.45 | −16 |
4 | 600e | −23 | NA | 125 | +39 | 1.33 | −8 | |
22 | 735e | −37 | NA | 102 | +71 | 1.91 | −36 | |
15 | 547e | −16 | NA | 137 | +27 | 2.94 | −58 |
NA, not available; V/F, apparent distribution volume; V/BW, weight-normalized distribution volume; AUC, area under the curve from time zero to infinity for single-dose studies or between two doses at steady state for repeated-dose studies; Δ%, relative change (in percent) compared to the results of the cited study.
Normalized for a 75-mg dose.
The values are CL/BW (in liters/h/kg).
The values are V/BW (in liters/kg).
Derived from AUC and dose.